Results 161 to 170 of about 6,867 (211)
B-cell subsets in leprosy lesions: unraveling the complex interplay. [PDF]
Fróes LAR +3 more
europepmc +1 more source
Revealing Erythema Nodosum Leprosum in a Leprosy Patient: A Case of Treatment Noncompliance. [PDF]
Alhariri B +5 more
europepmc +1 more source
Atypical cutaneous manifestations: When leprosy and syphilis overlap. [PDF]
Souza NY +4 more
europepmc +1 more source
Estimation of Serum Vitamin D Levels and Helminthic Coinfection in Patients with Type 2 Lepra Reactions and its Correlation with Severity of Type 2 Reactions: A Cross-Sectional Study. [PDF]
Nayak N +5 more
europepmc +1 more source
Defective production of monocyte-activating cytokines in lepromatous leprosy.
We have examined the capacity of monocytes from patients with leprosy to undergo activation and the capacity of mononuclear cells from these patients to incorporate [3H]thymidine and produce monocyte-activating cytokines.
Marcus A Horwitz, W R Levis, Z A Cohn
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Clinical Neuromuscular Disease, 1999
Leprosy still remains a major cause of peripheral neuropathy, particularly in Asia, Africa, and immigrants from these endemic regions of the world. Lepromatous neuropathy can manifest as mononeuropathies, mononeuropachy multiplex, or as a generalized sensorimotor polyneuropathy. The electrophysiologic studies reveal a primarily axoral process, although
D J, Altman, A, Amato
openaire +2 more sources
Leprosy still remains a major cause of peripheral neuropathy, particularly in Asia, Africa, and immigrants from these endemic regions of the world. Lepromatous neuropathy can manifest as mononeuropathies, mononeuropachy multiplex, or as a generalized sensorimotor polyneuropathy. The electrophysiologic studies reveal a primarily axoral process, although
D J, Altman, A, Amato
openaire +2 more sources
Isoniazid in lepromatous leprosy
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1954Abstract 1. (1) Isoniazid was given a 6-months trial in eight patients suffering from lepromatous leprosy, some of whom had responded very poorly to previous sulphone treatment. 2. (2) Some form of lepra reaction occurred in all cases, causing treatment to be temporarily interrupted in two instances and dosage to be limited in two others. 3.
W H, JOPLING, D S, RIDLEY
openaire +2 more sources
Experimental Lepromatous Leprosy
Nature, 1967Injection of Mycobacterium leprae has produced leprosy in mice previously thymectomized and given 900 r. of whole body irradiation to depress their immunological capacity.
R J, Rees +3 more
openaire +2 more sources
Relapses in lepromatous leprosy
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1956Abstract 1. (1) West African lepromatous patients whom modern treatment has rendered bacteriologically negative are liable to develop relapses in the form of fresh outcrops of macules even in spite of continued treatment. 2. (2) These relapses show clinical and histopathological characteristics of the dimorphous (indeterminate) form of ...
openaire +2 more sources

